Literature DB >> 1833097

High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction?

K T Nouri Aria1, M Lombard, R Williams.   

Abstract

Reduced suppressor cell number and function have been described in a number of autoimmune diseases and this may contribute to pathogenesis. Suppressor cell function depends upon the interaction of the CD8 antigen expressed on suppressor cells with other limbs of the immune system. Recently, soluble membrane antigens including CD8 have been identified in serum and it is possible that the loss of such antigens from viable cells could result in functional deficit. In order to examine whether the decreased suppressor cell function reported in autoimmune type of chronic liver disease is associated with soluble serum CD8 levels, sera from 23 patients with primary biliary cirrhosis (PBC), 12 with autoimmune chronic active hepatitis (AI-CAH) and 21 healthy controls were tested using a commercially available enzyme immunoassay. The proportion of cells expressing the CD8 antigen and the intensity of its display were also determined using an immunofluorescent technique and an ELISA, respectively, for 12 PBC and 10 healthy controls. The soluble serum CD8 levels were significantly higher in PBC (mean U/ml +/- s.d., 777 +/- 331), and AI-CAH (575 +/- 291) than controls (322 +/- 115) (P less than 0.001 and P = 0.004, respectively). While the intensity of CD8 antigen expression on suppressor/cytotoxic populations was not significantly different in PBC (347 +/- 125 per 10(4) cells) compared with controls (441 +/- 206), the mean proportion of CD8 positive cells was significantly less in PBC (14.1 +/- 6.8%) than controls (20 +/- 4.7%) (P less than 0.05). These data suggest that the apparent reduction in suppressor cell number found for patients with PBC and AI-CAH may be a consequence of the shedding or secretion of CD8 antigen from cell membrane of CD8 positive lymphocyte. It is also possible that the loss of this antigen is responsible for the reduced suppressor cell function seen in these conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833097      PMCID: PMC1554168          DOI: 10.1111/j.1365-2249.1991.tb05786.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Soluble CD8 in patients with rheumatic diseases.

Authors:  J A Symons; N C Wood; F S di Giovine; G W Duff
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  Cell-cell adhesion mediated by CD8 and MHC class I molecules.

Authors:  A M Norment; R D Salter; P Parham; V H Engelhard; D R Littman
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

Review 3.  Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology.

Authors:  M E Gershwin; R L Coppel; I R Mackay
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

4.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

5.  Quantification of soluble E-receptor in the serum of patients with various diseases and its accompanying in vitro immunosuppression in neoplasia.

Authors:  S K Oh; D Lapenson; A C Morgan
Journal:  Scand J Immunol       Date:  1985-07       Impact factor: 3.487

6.  Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease.

Authors:  G J Alexander; K T Nouri-Aria; A L Eddleston; R Williams
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

7.  NIH conference: Primary biliary cirrhosis: a model autoimmune disease.

Authors:  S P James; J H Hoofnagle; W Strober; E A Jones
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

8.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Immunochemical analysis of the released Leu-2 (T8) molecule.

Authors:  J Fujimoto; S J Stewart; R Levy
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

10.  Spontaneous release of the Leu-2 (T8) molecule from human T cells.

Authors:  J Fujimoto; S Levy; R Levy
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  3 in total

1.  Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC).

Authors:  K Yamamoto; S M Akbar; T Masumoto; M Onji
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

2.  Soluble CD4 and CD8 molecules in patients with systemic sclerosis.

Authors:  Y Tokano; H Kaneko; T Obara; H Hashimoto; K Okumura; S Hirose
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

3.  High serum levels of soluble CD8 in insulin-dependent diabetes.

Authors:  E Di Cesare; M Previti; M C Ingemi; G F Bagnato; D Cucinotta
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.